Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about BEAM
Recent news which mentions BEAM
< Previous
1
2
3
4
5
6
7
8
Next >
Is Beam Therapeutics a Good Stock to Buy Now?
January 16, 2022
Tickers
BEAM
CRSP
NTLA
PFE
Tags
Recent Press Releases
CRSP
Market News
From
Motley Fool
Why Editas Medicine Stock Is Tumbling This Week
January 13, 2022
Tickers
BEAM
EDIT
PFE
Tags
Recent Press Releases
Market News
PFE
From
Motley Fool
Expert Ratings For Beam Therapeutics
January 10, 2022
Tickers
BEAM
Tags
Analyst Ratings
Market News
Benzinga
From
Benzinga
Pfizer, Beam Ink Multi-Target Research Collaboration For In Vivo Base Editing Programs
January 10, 2022
Tickers
BEAM
PFE
Tags
Briefs
Trading Ideas
Gene Editing
From
Benzinga
My 3 Top Biotech Stock Picks for 2022
January 09, 2022
Tickers
AMGN
BEAM
GSK
VIR
Tags
XBI
VIR
GSK
From
Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2022
January 05, 2022
Tickers
ACAD
ADBE
ADTH
AEL
Tags
STXS
DLR
KLAC
From
Benzinga
Top 5 Moonshots for 2022 Countdown: My No. 5 Pick
December 22, 2021
Tickers
BEAM
BTU
CRSP
EBAY
Tags
SQUID/USD
BTU
SAFEMOON/USD
From
InvestorPlace
8 Beaten-Down Pharmaceutical Stocks That Could Skyrocket In 2022
December 07, 2021
Tickers
ADAP
AFMD
AUPH
AXSM
Tags
XBI
FOLD
Recent Press Releases
From
Motley Fool
Got $1,000? Check Out These 3 Top Biotech Stocks
December 03, 2021
Tickers
BEAM
GILD
VRTX
Tags
GILD
VRTX
BEAM
From
Motley Fool
Direxion Launches New Nanotechnology ETF, TYNE
November 23, 2021
Tickers
ALKS
ANGO
ARCT
BEAM
Tags
NNDM
BNTX
rafferty asset management
From
ETF Trends
Being First Is Not Enough For Crispr Therapeutics
November 15, 2021
Tickers
ALLO
BEAM
CRSP
MRNA
Tags
ALLO
CRSP
Hot Stocks
From
InvestorPlace
In Conversation: CMC Markets and ARK Investment Management on the Future of Genomic Testing
November 12, 2021
Tickers
BEAM
Tags
CMC Markets
Market News
BEAM
From
Benzinga
Cathie Wood's Buying Beam Therapeutics -- Should You?
November 09, 2021
Tickers
ALLO
BEAM
CRSP
Tags
Market News
CRSP
Recent Press Releases
From
Motley Fool
Looking Into Beam Therapeutics's Return On Capital Employed
November 08, 2021
Tickers
BEAM
Tags
Market News
Benzinga
BZI/ROCE
From
Benzinga
3 Stocks Cathie Wood Is Buying That You Might Want to Consider Too
October 26, 2021
Tickers
ARKF
ARKG
ARKK
ARKW
Tags
VRTX
BEAM
ARKW
From
Motley Fool
If I Could Only Own 1 Healthcare Stock, This Is What It Would Be
October 21, 2021
Tickers
ARKG
BEAM
DIS
EXAS
Tags
ARKG
DIS
LLY
From
Motley Fool
Sana Obtains License To Beam Therapeutics' CRISPR Cas12b Gene Editing Technology
October 19, 2021
Tickers
BEAM
SANA
Tags
Movers
Health Care
Contracts
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 19, 2021
October 19, 2021
Tickers
ACI
ALB
ARBE
ARGX
Tags
HLTH
ZG
CS
From
Benzinga
2 Gene-Editing Stocks to Have on Your Radar Right Now
October 17, 2021
Tickers
ARKG
ARKK
BEAM
CRSP
Tags
NTLA
ARKK
CRSP
From
Motley Fool
Why Shares of Allogene Therapeutics, Beam Therapeutics, Intellia Therapeutics, and Schrödinger Are Volatile This Week
October 15, 2021
Tickers
ALLO
BEAM
CRSP
NTLA
Tags
SDGR
ALLO
REGN
From
Motley Fool
Cathie Wood Goes Dumpster Diving: 3 Sagging Stocks She Just Bought
October 12, 2021
Tickers
ALLO
AMRS
ARKK
BEAM
Tags
ARKK
ALLO
DNA
From
Motley Fool
Got $500? 3 Game-Changing Stocks to Buy Right Now
October 04, 2021
Tickers
ABNB
BEAM
FB
MTTR
Tags
MTTR
Market News
BEAM
From
Motley Fool
Step Aside, Genomic Revolution. Welcome, the Proteomic Revolution!
October 03, 2021
Tickers
BEAM
Tags
BEAM
NASDAQ:BEAM
Hot Stocks
From
InvestorPlace
3 Most Overvalued Biotech Stocks on the Market Right Now
October 01, 2021
Tickers
BEAM
BNTX
CRSP
CVAC
Tags
MRNA
NTLA
Market News
From
Motley Fool
Breaking Down CRISPR Technology
September 28, 2021
Tickers
BEAM
CRBU
CRSP
EDIT
Tags
EDIT
CRSP
REGN
From
Motley Fool
Beam Therapeutics' Base Editors Show Encouraging Preclinical Action In HBV Infection
September 27, 2021
Tickers
BEAM
Tags
Biotech
Benzinga
Preclinical Phase
From
Benzinga
The Daily Biotech Pulse: Restricted Authorization For Pfizer's COVID-19 Booster Dose, AbCellera Strikes Antibody Licensing Deal, Solid Biosciences Issues DMD Data
September 23, 2021
Tickers
ABCL
ABSI
AFIB
ALZN
Tags
DXCM
PSTX
ALZN
From
Benzinga
Beam Therapeutics' Formulated LNP Show Tolerance, Early Storage Stability In Animal Studies
September 23, 2021
Tickers
BEAM
Tags
Gene Editing
Preclinical Phase
Briefs
From
Benzinga
Why Cathie Wood Is Buying 2 Gene-Editing Stocks but Selling Another
September 23, 2021
Tickers
ARKG
ARKK
BEAM
CLLS
Tags
VRTX
CRBU
BEAM
From
Motley Fool
Beam Therapeutics's Return On Capital Employed Insights
September 22, 2021
Tickers
BEAM
Tags
Earnings
BZI/ROCE
BEAM
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today